Innovation Forum Events

Pitch in the Pub – Innovation Forum Cambridge

Tuesday, May 16th 2023

Add to calendar

19:00 – 21:30 (GMT)

Panton Arms, 43 Panton St, Cambridge CB2 1HL

View map

Do you want to attend? Get your ticket!

Register Now


Finally, we’re back to face-to-face events!

Are you interested in entrepreneurship, technology, and life sciences? If so, then you won't want to miss our upcoming Pitch in a Pub event! Join us at the Panton Arms in Cambridge on the 16th of May at 7.00 pm for an evening of networking, discussion, and innovation.

Pitch in a Pub is a series of events hosted by The Innovation Forum Cambridge that brings together entrepreneurs, academics, professionals, researchers, and those who want to join this space to explore the latest trends and opportunities in the life sciences and technology sectors. Our guest speakers will share their business pitches and passion for innovation, followed by lively discussions with the audience.

Whether you're looking for a co-founder, your next investment, or to get involved in the innovation community, this event is for you!

This is the perfect opportunity to hear from both experienced and new entrepreneurs who are building the next steps of health innovation. You'll gain valuable insights into their stories, and learn how you can follow in their footsteps and start your own venture.

Pitch in a Pub is hosted by The Innovation Forum, a global non-profit network of founders, academics, and professionals driving innovative healthcare technology development by facilitating connections between members of the community. Don't miss out on this exciting event!

Space is limited so sign up today for FREE!


7pm - 7.10pm

Set up and get your drinks!

7.10pm - 7.20pm


7.20pm - 7.40pm

Pitch 1 – Hendrick Runge, Founder – Cambridge Nucleomics

7.40pm - 8pm

Pitch 2 – Tim Chisholm, Founder – Neurothread

8pm - 8.10pm


8.10pm - 8.30pm

Founding Story – Paul Roberts, Founder – CMR Surgical

8.30pm - 9.30pm



Cambridge Nucleomics develops an ultra-fast one-hour sepsis test by directly detecting and identifying pathogen rRNAs without intermediate steps; the current gold standard test takes over a day. They developed nanopore-based RNA analysis technology 1000x faster than other sequencing methods. At scale, their point-of-care testing device will detect 80 bacteria and fungi from 10 ml of blood in just 1 hour in a fully automated fashion; at present, they have a laboratory-scale prototype, two patents and published proof-of-concept for bacterial rRNA and viral RNA detection. The spin-out from Ulrich Keyser’s group at the Cavendish Laboratory is currently focusing on fungal infections in cancer patients following chemotherapy and the immunosuppressed, as fast detection of fungi is challenging with existing methods and fungicides can cause dose-limiting side effects during treatment. Cambridge Nucleomics’ test will not only identify fungal cells in the blood to determine the optimal treatment but also monitor treatment efficacy in vivo in near real-time from blood samples taken during treatment. Cambridge Nucleomics is raising £1M to expand proof-of-concept to human samples, for which they are negotiating access to biobanks from UC Davis and Galeazzi Hospital in Milan. The technology has further applications across laboratory tools, RNA drugs and gene therapy.

In the UK 1 million people suffer from dementia or movement disorders, such as Parkinson’s disease. Many of these diseases look similar at an early stage but progress very differently. In the UK, 20% of cases are initially misdiagnosed leading to uncertainty for patients and their families and an increased burden on the NHS.

At Neurothread we are developing an early and accurate diagnostic test for Parkinson’s and related diseases. Our solution is a rapid blood test that can distinguish closely related diseases, and can identify these diseases before physical and cognitive symptoms appears. Early and accurate diagnosis provides certainty for patients, reduces hospitalisations, and delays care home admissions. Our solution therefore allows patients to get the certainty and disease management they need.

CMR Surgical is a global medical devices company dedicated to transforming surgery with Versius®, a next-generation surgical robot.
CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool to make robotic minimal access surgery universally accessible and affordable.
Paul Roberts is a business and technology leader with over 15 years’ research and product development experience. Paul is passionate about encouraging, motivating and leading excellent teams to deliver a great customer experience. Prior to founding CMR, Paul led and grew capability in complex medical device development at the Science Group Plc.

We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. By continuing to use our services, you are giving us your consent to use cookies. Learn more here.